![]() Following the introduction of new variants and changes to COVID-19 restrictions, Orbis adapted to the suit new testing demands and moved towards a broader system for the platform, enabling Orbis to take on infectious diseases and various different types of assays. With Orbis Clinical, you're not in it alone. ![]() With the outbreak of COVID-19, Orbis recognised how the unique features of the system could help people determine their relative level of immunity following vaccination and quickly repurposed the technology to deliver a quantitative immunity test for COVID-19. FDA provides for the verification of the clinical trial results by analyzing the submitted tabulation and analysis datasets. Orbis has trialed its technology on a wide range of fluid media and analytes, including measuring progesterone in milk to inform the timing of artificial insemination. Orbis has developed the Arca, a ‘lab on a disk’ testing platform that uses proprietary microfluidic technology to miniaturise and automate accurate lab testing for use at the point of care. Orbis brings together a proven team of world-leading scientists, backed by New Zealand’s largest early stage deep-tech investor, Pacific Channel. High quality, accessible diagnostics enable individuals within society to make life-changing decisions with confidence. This is despite the publication of many scientific guidelines, interactions/meetings with regulators and the establishment of dedicated review timelines by. Project Orbis provides a framework for concurrent submission and review of oncology drugs. is a three-arm, randomised clinical trial being conducted in Ethiopia. Development of new drugs is a challenging and complex process associated with long development timelines and clinical trial success rates for compounds entering phase I of around 10 1, 2. This review was conducted under Project Orbis, an initiative of the FDA Oncology Center of Excellence. 2 Department of Epidemiology, University of North Carolina at Chapel Hill. Orbis Diagnostics believes everyone should be empowered to understand their true health status, irrespective of who they are and where they live. 1 Orbis International Ethiopia, Addis Ababa, Ethiopia. Our mission: to make complex medical testing simple and accessible wherever and whenever needed.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |